102 related articles for article (PubMed ID: 2124607)
21. Immunoregulatory and antitumor activity of schizophyllan under ultrasonic treatment.
Zhong K; Tong L; Liu L; Zhou X; Liu X; Zhang Q; Zhou S
Int J Biol Macromol; 2015 Sep; 80():302-8. PubMed ID: 26126943
[TBL] [Abstract][Full Text] [Related]
22. [Two cases of cancer with bone metastases treated with local therapy].
Kurokawa T; Tamakuma S
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1717-9. PubMed ID: 8373257
[TBL] [Abstract][Full Text] [Related]
23. Preparation and antitumor activities of beta-(1-->6) branched (1-->3)-beta-D-glucan derivatives.
Usui S; Tomono Y; Sakai M; Kiho T; Ukai S
Biol Pharm Bull; 1995 Dec; 18(12):1630-6. PubMed ID: 8787778
[TBL] [Abstract][Full Text] [Related]
24. [Clinical efficacies of schizophyllan (SPG) on advanced gastric cancer].
Fujimoto S
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1447-50. PubMed ID: 2531270
[TBL] [Abstract][Full Text] [Related]
25. [Antitumor activity of schizophyllan (SPG) against syngeneic ACI/N rat tumor, AMC-60 fibrosarcoma and BC-47 bladder cancer].
Mitani M; Arika T; Matsuo T; Asano T
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1809-17. PubMed ID: 6236752
[TBL] [Abstract][Full Text] [Related]
26. Improvement of long-term prognosis in patients with ovarian cancers by adjuvant sizofiran immunotherapy: a prospective randomized controlled study.
Inoue M; Tanaka Y; Sugita N; Yamasaki M; Yamanaka T; Minagawa J; Nakamuro K; Tani T; Okudaira Y; Karita T
Biotherapy; 1993; 6(1):13-8. PubMed ID: 8507540
[TBL] [Abstract][Full Text] [Related]
27. Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer.
Yamamoto K; Noda K; Hatae M; Kudo T; Hasegawa K; Nishimura R; Honjo H; Yajima A; Sato S; Mizutani K; Yakushiji M; Terashima Y; Ochiai K; Sasaki H; Ozaki M
Oncol Rep; 2001; 8(2):273-7. PubMed ID: 11182039
[TBL] [Abstract][Full Text] [Related]
28. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
Mochizuki S; Morishita H; Kobiyama K; Aoshi T; Ishii KJ; Sakurai K
J Control Release; 2015 Dec; 220(Pt A):495-502. PubMed ID: 26562685
[TBL] [Abstract][Full Text] [Related]
29. Augmentation of antitumor effect by combined administration with interleukin-2 and sizofiran, a single glucan, on murine EL-4 lymphoma.
Kano Y; Kakuta H; Hashimoto J
Biotherapy; 1996; 9(4):241-7. PubMed ID: 9012543
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of pulmonary metastasis of Lewis lung carcinoma by a glucan, Schizophyllan.
Yamamoto T; Yamashita T; Tsubura E
Invasion Metastasis; 1981; 1(1):71-84. PubMed ID: 6234252
[TBL] [Abstract][Full Text] [Related]
31. Clinical outcome of postoperative adjuvant immunochemotherapy with sizofiran for patients with resectable gastric cancer: a randomised controlled study.
Fujimoto S; Furue H; Kimura T; Kondo T; Orita K; Taguchi T; Yoshida K; Ogawa N
Eur J Cancer; 1991; 27(9):1114-8. PubMed ID: 1835619
[TBL] [Abstract][Full Text] [Related]
32. A case report of recurrent cervical cancer which responded to a combination of biological therapies.
Goto S; Sakai S; Kera J; Suma Y; Soma GI; Takeuchi S
Eur J Gynaecol Oncol; 1994; 15(3):235-40. PubMed ID: 7957329
[TBL] [Abstract][Full Text] [Related]
33. [Sizofiran and recombinant interferon gamma stimulate peritoneal macrophages obtained from patients with gynecologic malignancies--increased secretion of tumor necrosis factor, IL-1 and interferon-gamma].
Chen JT; Teshima H; Shimizu Y; Hasumi K; Masubuchi K; Suzuki M
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1365-9. PubMed ID: 2142400
[TBL] [Abstract][Full Text] [Related]
34. [Effect of sizofiran or recombinant interferon gamma on the activation of human peritoneal macrophage function; an approach for the prophylaxis of intraperitoneal recurrence of ovarian cancer].
Chen JT; Teshima H; Shimizu Y; Hasumi K; Masubuchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):179-84. PubMed ID: 2138205
[TBL] [Abstract][Full Text] [Related]
35. [Clinical evaluation of schizophyllan (SPG) in advanced gastric cancer--a randomized comparative study by an envelope method].
Nakao I; Uchino H; Orita K; Kaido I; Kimura T; Goto Y; Kondo T; Takino T; Taguchi T; Nakajima T; Fujimoto S; Miyazaki T; Miyoshi A; Yachi A; Yoshida K; Ogawa N; Furue H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1146-59. PubMed ID: 6223584
[TBL] [Abstract][Full Text] [Related]
36. Combination therapy of pions and SPG (Sonifilan, Schizophyllan), a biological response modifier for mouse tumor systems.
Ogawa Y; Goodman GB; Chaplin DJ; Grulkey W; Lam GK
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1415-20. PubMed ID: 2142485
[TBL] [Abstract][Full Text] [Related]
37. In vitro activation of human adherent cells by a glucan, Schizophyllan.
Mashiba H; Matsunaga K
Jpn J Exp Med; 1983 Aug; 53(4):195-8. PubMed ID: 6229661
[TBL] [Abstract][Full Text] [Related]
38. Augmenting effect of sizofiran on the immunofunction of regional lymph nodes in cervical cancer.
Shimizu Y; Hasumi K; Masubuchi K
Cancer; 1992 Mar; 69(5):1184-94. PubMed ID: 1739919
[TBL] [Abstract][Full Text] [Related]
39. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
[TBL] [Abstract][Full Text] [Related]
40. Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7.
Steller MA; Gurski KJ; Murakami M; Daniel RW; Shah KV; Celis E; Sette A; Trimble EL; Park RC; Marincola FM
Clin Cancer Res; 1998 Sep; 4(9):2103-9. PubMed ID: 9748126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
